Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed Mar 8, 2012 · 10-K · 68 days after period end · 0001062822-12-000010
| Metric | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|
| Revenue | $343.00K | — |
| Net Income | -$33.85M | — |
| EPS Diluted | -$0.10 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 8, 2012 · 68 d after period end
